Aakash Desai

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 20

Top Topics

Bariatric Surgery

Ulcerative Colitis

Patients With Inflammatory Bowel Disease

Respiratory Syncytial Virus

Top Venues

The American journal of gastroenterology

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

Journal of Crohn's & colitis

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan A Smith, Aakash Desai, Edward L Barnes, Mary S Hayney, Gursimran S Kochhar, Jana G Hashash, Francis A Farraye, Freddy Caldera
Patients with Inflammatory Bowel Disease are at Increased Risk for Hospitalization Due to Respiratory Syncytial Virus. The American journal of gastroenterology (2024)
Ryan A Smith, Aakash Desai, Edward L Barnes, Mary S Hayney, Gursimran S Kochhar, Jana G Hashash, Francis A Farraye, Freddy Caldera
Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus. The American journal of gastroenterology 119 (8) (2024)
Aakash Desai, Jessica Petrov, Jana G Hashash, Harsh Patel, Bhaumik Brahmbhatt, Gursimran S Kochhar, Francis A Farraye
Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease. Alimentary pharmacology & therapeutics 60 (5) (2024)
Edward L Barnes, Aakash Desai, Jana G Hashash, Francis A Farraye, Gursimran S Kochhar
The Natural History after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study from the United States. The American journal of gastroenterology (2024)
Gursimran S Kochhar, Himsikhar Khataniar, Vipul Jairath, Francis A Farraye, Aakash Desai
Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A US Propensity-Matched Cohort Study. The American journal of gastroenterology (2024)
Aakash Desai, Himsikhar Khataniar, Jana G Hashash, Francis A Farraye, Miguel Regueiro, Gursimran S Kochhar
Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity. Inflammatory bowel diseases (2024)
Aakash Desai, Jana G Hashash, Gursimran S Kochhar, Mary S Hayney, Freddy Caldera, Francis A Farraye
Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study. Journal of Crohn's & colitis 18 (6) (2024)
Edward L Barnes, Aakash Desai, Jana G Hashash, Francis A Farraye, Gursimran S Kochhar
The Natural History After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study From the United States. The American journal of gastroenterology (2024)
Ryan A Smith, Aakash Desai, Edward L Barnes, Mary S Hayney, Gursimran S Kochhar, Jana G Hashash, Francis A Farraye, Freddy Caldera
Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus. The American journal of gastroenterology (2024)
Gursimran S Kochhar, Himsikhar Khataniar, Vipul Jairath, Francis A Farraye, Aakash Desai
Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A U.S. Propensity-Matched Cohort Study. The American journal of gastroenterology (2024)
Aakash Desai, Jessica Petrov, Jana G Hashash, Harsh Patel, Bhaumik Brahmbhatt, Gursimran S Kochhar, Francis A Farraye
Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease. Alimentary pharmacology & therapeutics (2024)
Aakash Desai, Jana G Hashash, Gursimran S Kochhar, Mary S Hayney, Freddy Caldera, Francis A Farraye
Recombinant Zoster Vaccine (RZV) is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study. Journal of Crohn's & colitis (2024)
Edward L Barnes, Aakash Desai, Gursimran S Kochhar
The Comparative Effectiveness of Ciprofloxacin and Metronidazole for an Initial Episode of Pouchitis: A Propensity Matched Study. The American journal of gastroenterology (2023)
Aakash Desai, Aakriti Soni, Mary S Hayney, Jana G Hashash, Gursimran S Kochhar, Francis A Farraye, Freddy Caldera
Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study. Inflammatory bowel diseases (2023)
Gursimran S Kochhar, Aakash Desai, Francis A Farraye, Raymond K Cross, Sandra El-Hachem, Parambir S Dulai, Miguel Regueiro
Efficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort study. Alimentary pharmacology & therapeutics (2023)
Aakash Desai, Jana G Hashash, Gursimran S Kochhar, Francis A Farraye
Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study. Crohn's & colitis 360 5 (3) (2023)
Aakash Desai, Miguel Regueiro, Gursimran S Kochhar
Letter: Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis-Authors' reply. Alimentary pharmacology & therapeutics 58 (11-12) (2023)
Ryan A Smith, Aakash Desai, Jana G Hashash, Mary S Hayney, Francis A Farraye, Freddy Caldera
Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines. Inflammatory bowel diseases (2023)
Aakash Desai, Jana G Hashash, Gianna Baker, Francis A Farraye, Nisheet Waghray, Gursimran S Kochhar
Effect of Bariatric Surgery on Disease Outcomes in Patients with Inflammatory Bowel Disease: A US-based Propensity Matched Cohort Study. Journal of clinical gastroenterology (2023)
Aakash Desai, Parakkal Deepak, Raymond K Cross, Julie Murone, Francis A Farraye, Ryan C Ungaro, Gursimran S Kochhar
Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis. Inflammatory bowel diseases (2022)